First Time Loading...

WAVE Life Sciences Ltd
NASDAQ:WVE

Watchlist Manager
WAVE Life Sciences Ltd Logo
WAVE Life Sciences Ltd
NASDAQ:WVE
Watchlist
Price: 6.14 USD 4.42% Market Closed
Updated: May 5, 2024

WAVE Life Sciences Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

WAVE Life Sciences Ltd
Revenue Peer Comparison

Comparables:
H02
H
1J5
I
42C

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
WAVE Life Sciences Ltd
NASDAQ:WVE
Revenue
$113.3m
CAGR 3-Years
78%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Haw Par Corporation Ltd
SGX:H02
Revenue
S$232.1m
CAGR 3-Years
28%
CAGR 5-Years
0%
CAGR 10-Years
5%
H
Hyphens Pharma International Ltd
SGX:1J5
Revenue
S$170.6m
CAGR 3-Years
12%
CAGR 5-Years
7%
CAGR 10-Years
N/A
I
IX Biopharma Ltd
SGX:42C
Revenue
S$6.1m
CAGR 3-Years
59%
CAGR 5-Years
75%
CAGR 10-Years
N/A

See Also

What is WAVE Life Sciences Ltd's Revenue?
Revenue
113.3m USD

Based on the financial report for Dec 31, 2023, WAVE Life Sciences Ltd's Revenue amounts to 113.3m USD.

What is WAVE Life Sciences Ltd's Revenue growth rate?
Revenue CAGR 5Y
51%

Over the last year, the Revenue growth was 3 004%. The average annual Revenue growth rates for WAVE Life Sciences Ltd have been 78% over the past three years , 51% over the past five years .